Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Mingjie Jiang

Matched on ORCID iD 0000-0001-8798-9904; OpenAlex author ID A5013862994. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 10

  1. Pancreatic cancer cells hijack tumor suppressive microRNA-26a to promote radioresistance and potentiate tumor repopulation. Co-author DOI 10.1016/j.heliyon.2024.e31346↗
  2. Correction to: microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings. Co-author DOI 10.1186/s13046-021-02180-6↗
  3. MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer. Co-author DOI 10.1155/2020/2782101↗
  4. Analysis of exosomal circRNAs upon irradiation in pancreatic cancer cell repopulation. First author DOI 10.1186/s12920-020-00756-3↗
  5. Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer. Co-author DOI 10.1186/s12943-020-01178-6↗
  6. KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma. Co-author DOI 10.4251/wjgo.v11.i8.599↗
  7. miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2. Co-author DOI 10.1038/s41419-018-1182-9↗
  8. microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings. Co-author DOI 10.1186/s13046-018-0697-3↗
  9. microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression. First author DOI 10.1016/j.canlet.2017.04.020↗
  10. Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. Co-author DOI 10.1016/j.bbcan.2016.08.002↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dian-na Gu · 7 shared papers, 2016–2024 · strength 0.90
  2. Ling Tian · 5 shared papers, 2017–2021 · strength 0.59
  3. Qian Huang · 4 shared papers, 2016–2020 · strength 0.36
  4. Chi Fang · 3 shared papers, 2017–2021 · strength 0.31
  5. Ling Tian · 1 shared paper, 2024 · strength 0.26
  6. Qiuyan Zhao · 2 shared papers, 2018–2019 · strength 0.18
  7. Yi-yun Chen · 1 shared paper, 2020 · strength 0.16
  8. Qian Huang · 1 shared paper, 2021 · strength 0.15
  9. Zhiqiang Ye · 1 shared paper, 2020 · strength 0.13
  10. Xingya Guo · 1 shared paper, 2019 · strength 0.09
  11. Weiliang Jiang · 1 shared paper, 2019 · strength 0.09
  12. Sisi Li · 1 shared paper, 2019 · strength 0.09
  13. Rong Wan · 1 shared paper, 2019 · strength 0.09
  14. Zhonglin Zhu · 1 shared paper, 2018 · strength 0.09
  15. Baiwen Li · 1 shared paper, 2018 · strength 0.09
  16. Lanting Yu · 1 shared paper, 2018 · strength 0.09
  17. Ling Tian · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.